DCGN: Q3 Earnings Call @ 08:00 ET Today [delayed] -
BRIEF-DeCODE genetics Q3 results -
deCODE genetics Announces Third Quarter 2008 Financial Results -
deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter -
deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results -
deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business -
deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer -
DCGN: Launch of deCODE BreastCancer(TM) Genetic Test -
deCODE genetics files IND application for cognition drug -
deCODE Receives Nasdaq Deficiency Notice Relating to Market Value -
DCGN: Files IND Application w/FDA for DG071 -
deCODE and Radboud University discover common variants in cancer human genome -
DCGN: Discovery of Two Common Single-Letter Variants for Bladder Cancer -
DCGN: To Present At Thomas Weisel Healthcare Conference @ 13:30 ET [delayed] -